GlassScriptPhysician profile
Michael J Goldberg
NPI 1205843760
$2,067.02
in general payments reported to CMS, 2019-2025
19 companies · $589 in 2025
The $589 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $34.41 · 2022: $290 · 2023: $512 · 2024: $467 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472 · Honoraria: $48.05 · Gift: $30.01 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.97 |
| Honoraria | $48.05 |
| Gift | $30.01 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $506.23 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Abbvie INC. | $274.24 | 2023-2025 | |
| Apellis Pharmaceuticals, INC. | $174.82 | 2023-2025 | Syfovre |
| Johnson & Johnson Surgical Vision, INC. | $143.09 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $126.26 | 2019-2024 | |
| Rayner Intraocular Lenses Limited | $124.99 | 2024 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Alcon Vision LLC | $122.52 | 2020-2025 | Rocklatan, Precision7, Eysuvis |
| Sun Pharmaceutical Industries INC. | $122.22 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $102.86 | 2022-2024 | Eylea, Eylea Hd |
| Tarsus Pharmaceuticals, INC. | $81.06 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.48 | 2019 | |
| Coherus Oncology, INC. | $46.58 | 2023 | |
| Oyster Point Pharma, INC. | $43.88 | 2023-2025 | Tyrvaya, Ryzumvi |
| Glaukos Corporation | $26.89 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Mallinckrodt Hospital Products INC. | $25.23 | 2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25.16 | 2023 | |
| Coopervision INC. | $23.43 | 2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $17.84 | 2024 | Miebo |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.